MedPath

The effects of calcium and vitamin B1 supplementations on premenstrual syndrome

Phase 2
Conditions
Premenstrual Syndrome.
Premenstrual tension syndrome
Registration Number
IRCT2016011810333N3
Lead Sponsor
Ilam University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

The age ranges of 18 to 30 years; having body mass index between 18.5 to 30 kg/m2; having regular menstrual cycle with 24 to 35 days interval; experiencing at least 3 symptoms of PMS questionnaire’s criteria with moderate and severe intensity during 3 consecutive period cycles; having at least 5 signs of the DMS-IV criteria for premenstrual dysphoric disorder
Exclusion criteria: having any history of physical and mental illnesses; consuming anti-convulsants; consuming anti-depressants; consuming hormones and oral contraceptives; consuming multivitamin, vitamin B1 and calcium supplements during last 3 months.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in scores of premenstrual syndrome's questionnaire. Timepoint: Before and 2 months after the start of the intervention. Method of measurement: Standard questionnaire for premenstrual syndrome.
Secondary Outcome Measures
NameTimeMethod
Changes in scores of the premenstrual dysphoric disorder's questionnaire. Timepoint: Before and 2 months after the start of the intervention. Method of measurement: Standard questionnaire for premenstrual dysphoric disorder.
© Copyright 2025. All Rights Reserved by MedPath